{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Slice of Healthcare","title":"#536 - Is 340B really going away — or finally becoming infrastructure? | Kim Tzoumakas (CEO, VytlOne)","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/ad281941\"></iframe>","width":"100%","height":180,"duration":1114,"description":"Kim Tzoumakas is the CEO of VytlOne, the nation's only independent, fully integrated total pharmacy solutions partner — the century-old company formerly known as Maxor, which she rebranded and merged with ProxsysRx in a fast-moving transformation after taking the helm in January 2025. VytlOne partners with mission-driven hospitals and health systems, combining pharmacy operations, 340B management, specialty pharmacy, pharmacy benefit management, and patient affordability solutions to help nonprofit providers unlock revenue and reinvest in their communities — work that generated $1.4 billion for its pharmacy partners in a single year. Its newest bet is VytlAIQ, an end-to-end intelligence platform built ground-up (not grafted onto a legacy system) that connects clinical, pharmacy, payer, and financial data into one real-time platform, surfacing next-best actions and checking every 340B claim for eligibility and documentation so problems get caught before they cost providers money. Kim came to pharmacy the long way around — two decades as a healthcare attorney embedded in hospitals and health systems, then CEO of RAYUS Radiology and 21st Century Oncology. Her core conviction is that 340B isn't a loophole to be abused or a relic on its way out; it's critical infrastructure that lets nonprofit health systems reinvest in patient care, and the real failure is that the tools serving it stayed reactive, fragmented, and manual. VytlOne's bet is that AI belongs in pharmacy not to replace clinical judgment or wipe out teams, but as an intelligent partner that tears down the administrative barriers — prior auth, denied claims, missing documentation — standing between a patient and their medication. The test of success: a patient who simply feels their care move faster and never once thinks about the software behind it.\nWe discuss:Why the first thing Kim checks in any business isn't the P&L — it's the boards, the ownership model, and financial stability that determine whether...","thumbnail_url":"https://img.transistorcdn.com/EjCTPN9LuAjKcezXWYD4dF6FTuJcOJeyRKNcRtmBK_g/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kNjZk/OTVhMjY1MWE3Y2Nl/OTEyODcxMDQwMzll/NzU2Ni5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}